Daiichi Sankyo Co Ltd

D4S

Company Profile

  • Business description

    Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

  • Contact

    3-5-1, Nihonbashi-honcho
    Chuo-ku
    Tokyo103-8426
    JPN

    T: +81 362251111

    https://www.daiichisankyo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2025

    Employees

    18,726

Stocks News & Analysis

stocks

Why ASX miners will handily beat banks in the long-term

After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years. 
stocks

How to avoid dividend disaster

Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,785.10101.701.17%
CAC 408,001.97110.291.40%
DAX 4021,866.98281.051.30%
Dow JONES (US)44,857.1816.10-0.04%
FTSE 1008,748.11124.821.45%
HKSE20,891.62294.531.43%
NASDAQ19,710.2217.890.09%
Nikkei 22539,066.53235.050.61%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,070.378.890.15%
S&P/ASX 2008,520.70103.801.23%
SSE Composite Index3,270.6641.171.27%

Market Movers